Consequently, some authors consider GLP-1 RAs to be safe in the IBD population, however, they emphasise the necessity of providing educational advice to patients (e.g. small and frequent meals) and employing a gradual dose-up titration strategy (114). This evidence concerns the gene GLP1R and inflammatory bowel disease.